99 related articles for article (PubMed ID: 11427216)
1. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality.
De Bacquer D; De Backer G; Langlois M; Delanghe J; Kesteloot H; Kornitzer M
Atherosclerosis; 2001 Jul; 157(1):161-6. PubMed ID: 11427216
[TBL] [Abstract][Full Text] [Related]
2. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin.
Cahill LE; Levy AP; Chiuve SE; Jensen MK; Wang H; Shara NM; Blum S; Howard BV; Pai JK; Mukamal KJ; Rexrode KM; Rimm EB
J Am Coll Cardiol; 2013 Feb; 61(7):728-37. PubMed ID: 23312704
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort.
Levy AP; Larson MG; Corey D; Lotan R; Vita JA; Benjamin EJ
Atherosclerosis; 2004 Feb; 172(2):361-5. PubMed ID: 15019547
[TBL] [Abstract][Full Text] [Related]
4. [Association of haptoglobin 1/2 polymorphism with coronary heart disease in Chinese].
Liu HB; Shi YP; Guo XF; Shan J; Xu G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):60-3. PubMed ID: 21287512
[TBL] [Abstract][Full Text] [Related]
5. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables.
Braeckman L; De Bacquer D; Delanghe J; Claeys L; De Backer G
Atherosclerosis; 1999 Apr; 143(2):383-8. PubMed ID: 10217368
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery.
Delanghe J; Cambier B; Langlois M; De Buyzere M; Neels H; De Bacquer D; Van Cauwelaert P
Atherosclerosis; 1997 Jul; 132(2):215-9. PubMed ID: 9242967
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype.
Cahill LE; Jensen MK; Chiuve SE; Shalom H; Pai JK; Flint AJ; Mukamal KJ; Rexrode KM; Levy AP; Rimm EB
J Am Coll Cardiol; 2015 Oct; 66(16):1791-1799. PubMed ID: 26483103
[TBL] [Abstract][Full Text] [Related]
8. Parental history of premature coronary heart disease mortality and signs of ischemia on the resting electrocardiogram.
De Bacquer D; De Backer G; Kornitzer M; Blackburn H
J Am Coll Cardiol; 1999 May; 33(6):1491-8. PubMed ID: 10334413
[TBL] [Abstract][Full Text] [Related]
9. Haptoglobin polymorphism and complications in established essential arterial hypertension.
Delanghe JR; Duprez DA; De Buyzere ML; Bergez BM; Callens BY; Leroux-Roels GG; Clement DL
J Hypertens; 1993 Aug; 11(8):861-7. PubMed ID: 8228210
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events.
Ijäs P; Saksi J; Soinne L; Tuimala J; Jauhiainen M; Jula A; Kähönen M; Kesäniemi YA; Kovanen PT; Kaste M; Lindsberg PJ
Atherosclerosis; 2013 Oct; 230(2):228-34. PubMed ID: 24075749
[TBL] [Abstract][Full Text] [Related]
11. Haptoglobin polymorphism and mortality in patients with tuberculosis.
Kasvosve I; Gomo ZA; Mvundura E; Moyo VM; Saungweme T; Khumalo H; Gordeuk VR; Boelaert JR; Delanghe JR; De Bacquer D; Gangaidzo IT
Int J Tuberc Lung Dis; 2000 Aug; 4(8):771-5. PubMed ID: 10949330
[TBL] [Abstract][Full Text] [Related]
12. Haptoglobin polymorphism in Korean patients with cardiovascular diseases.
Hong SH; Kang BY; Lim JH; Namkoong Y; Oh MY; Kim JQ; Lee CC
Hum Hered; 1997; 47(5):283-7. PubMed ID: 9358017
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin polymorphism and chronic hepatitis C.
Louagie HK; Brouwer JT; Delanghe JR; De Buyzere ML; Leroux-Roels GG
J Hepatol; 1996 Jul; 25(1):10-4. PubMed ID: 8836895
[TBL] [Abstract][Full Text] [Related]
14. Haptoglobin (HP) polymorphisms and human longevity: a cross-sectional association study in a Central Italy population.
Napolioni V; Giannì P; Carpi FM; Concetti F; Lucarini N
Clin Chim Acta; 2011 Mar; 412(7-8):574-7. PubMed ID: 21147083
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin polymorphism as a risk factor for chronic kidney disease: a case-control study.
Chen YC; Lee CC; Huang CY; Huang HB; Yu CC; Ho YC; Su YC
Am J Nephrol; 2011; 33(6):510-4. PubMed ID: 21546768
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent.
Awadallah S; Hamad M
Cytobios; 2000; 101(398):145-50. PubMed ID: 10755213
[TBL] [Abstract][Full Text] [Related]
17. Haptoglobin and myeloperoxidase (- G463A) gene polymorphisms in Brazilian sickle cell patients with and without secondary iron overload.
Barbosa LC; Miranda-Vilela AL; Hiragi Cde O; Ribeiro IF; Daldegan MB; Grisolia CK; dos Santos-Neto LL
Blood Cells Mol Dis; 2014; 52(2-3):95-107. PubMed ID: 24567965
[TBL] [Abstract][Full Text] [Related]
18. Interaction between a haptoglobin genetic variant and coronary artery disease (CAD) risk factors on CAD severity in Singaporean Chinese population.
Chang X; Dorajoo R; Han Y; Wang L; Liu J; Khor CC; Low AF; Chan MY; Yuan JM; Koh WP; Friedlander Y; Heng CK
Mol Genet Genomic Med; 2020 Oct; 8(10):e1450. PubMed ID: 32794371
[TBL] [Abstract][Full Text] [Related]
19. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese.
Na N; Delanghe JR; Taes YE; Torck M; Baeyens WR; Ouyang J
Clin Chim Acta; 2006 Mar; 365(1-2):319-24. PubMed ID: 16256097
[TBL] [Abstract][Full Text] [Related]
20. Age group-associated variations in the pattern of Hp type distribution in Jordanians.
Hamad M; Awadallah S
Clin Chim Acta; 2000 Oct; 300(1-2):75-81. PubMed ID: 10958864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
